Interleukin 1 receptor antagonist gene variable number of tandem repeats polymorphism and cutaneous melanoma.

cutaneous melanoma immunity innate response interleukin 1 family interleukin 1 receptor interleukin 1 receptor antagonist polymorphism skin cancer

Journal

Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 24 04 2019
accepted: 11 07 2019
entrez: 3 12 2019
pubmed: 4 12 2019
medline: 4 12 2019
Statut: ppublish

Résumé

Immunity and cytokines serve crucial roles in cutaneous melanoma. The present study investigated whether a variable number tandem repeat (VNTR) polymorphism of interleukin-1 receptor antagonist (IL-1RA) gene (

Identifiants

pubmed: 31788049
doi: 10.3892/ol.2019.10923
pii: OL-0-0-10923
pmc: PMC6865156
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5759-5768

Informations de copyright

Copyright: © Cauci et al.

Références

Iran J Immunol. 2018 Dec;15(4):321-328
pubmed: 30593746
Cytokine. 2005 Jun 7;30(5):293-302
pubmed: 15927855
Oncol Lett. 2016 Apr;11(4):2706-2714
pubmed: 27073541
PLoS One. 2012;7(9):e46017
pubmed: 23049925
Br J Dermatol. 2015 Apr;172(4):885-915
pubmed: 25354495
PLoS One. 2016 Apr 21;11(4):e0153975
pubmed: 27100888
Hum Mol Genet. 2018 Dec 1;27(23):4145-4156
pubmed: 30060076
Genomics. 1994 Jan 15;19(2):382-4
pubmed: 8188271
Eur J Immunol. 1998 Aug;28(8):2598-602
pubmed: 9710237
Immunity. 2013 Dec 12;39(6):1003-18
pubmed: 24332029
Nat Immunol. 2012 Mar 18;13(4):343-51
pubmed: 22430787
Geospat Health. 2016 Apr 18;11(1):422
pubmed: 27087039
Mol Cancer Res. 2011 Nov;9(11):1537-50
pubmed: 21954434
PLoS Comput Biol. 2014 Feb 13;10(2):e1003470
pubmed: 24550720
Expert Opin Biol Ther. 2018 Jul;18(sup1):77-83
pubmed: 30063847
Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):2394-400
pubmed: 11073843
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Immunol Rev. 2018 Jan;281(1):124-137
pubmed: 29247991
Science. 2013 Jan 18;339(6117):286-91
pubmed: 23329041
Oncol Lett. 2018 Oct;16(4):4105-4113
pubmed: 30214551
Oncol Lett. 2019 May;17(5):4197-4206
pubmed: 30944615
CA Cancer J Clin. 2016 Sep;66(5):370-4
pubmed: 26784705
Scand J Immunol. 1998 Mar;47(3):195-8
pubmed: 9519856
Mol Hum Reprod. 2007 Apr;13(4):243-50
pubmed: 17314118
Indian J Dermatol Venereol Leprol. 2018 May-Jun;84(3):285-291
pubmed: 29620037
Mol Genet Genomic Med. 2019 Jan;7(1):e00512
pubmed: 30523673
Lymphokine Res. 1986 Spring;5(2):77-85
pubmed: 3010001
Hum Genet. 1996 Jun;97(6):723-6
pubmed: 8641687
Immunol Rev. 2018 Jan;281(1):8-27
pubmed: 29247995
Mol Hum Reprod. 2003 Jan;9(1):53-8
pubmed: 12529421
Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1407-12
pubmed: 18451331
Arch Dermatol. 1988 Jun;124(6):869-71
pubmed: 3377516
J Clin Endocrinol Metab. 2006 Jul;91(7):2749-54
pubmed: 16636119
Int J Cancer. 2015 Jun 15;136(12):2890-9
pubmed: 25403087
Hum Genet. 1993 May;91(4):403-4
pubmed: 8500797
Curr Pharm Des. 2017;23(32):4794-4806
pubmed: 28721808
Clin Exp Immunol. 1995 Feb;99(2):303-10
pubmed: 7851026
PLoS One. 2018 Jan 29;13(1):e0190447
pubmed: 29377892
Clin Exp Otorhinolaryngol. 2018 Jun;11(2):118-123
pubmed: 29433161
Cancer Biol Med. 2017 Aug;14(3):302-318
pubmed: 28884047
Radiol Oncol. 2015 Nov 27;49(4):379-85
pubmed: 26834525
PLoS One. 2016 May 05;11(5):e0155004
pubmed: 27149110
BMC Med Genet. 2010 Feb 22;11:29
pubmed: 20175886
Immunol Rev. 2018 Jan;281(1):40-56
pubmed: 29247999
Nature. 2000 Mar 23;404(6776):398-402
pubmed: 10746728
Br J Dermatol. 1997 Jan;136(1):147-8
pubmed: 9039327
Int J Environ Res Public Health. 2015 Aug 05;12(8):9102-18
pubmed: 26251915
Immunol Rev. 2018 Jan;281(1):5-7
pubmed: 29248001
Cancer Metastasis Rev. 2015 Mar;34(1):115-28
pubmed: 25589384
Autoimmunity. 2017 Dec;50(8):468-475
pubmed: 29226727
Cancer Biol Med. 2017 May;14(2):162-175
pubmed: 28607807
Genes Immun. 2007 Jun;8(4):344-51
pubmed: 17443229
Immunol Rev. 2018 Jan;281(1):57-61
pubmed: 29247996
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
Oncotarget. 2017 Jun 16;8(43):75675-75686
pubmed: 29088901
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Clin Oncol. 2009 Dec 20;27(36):6199-206
pubmed: 19917835
Clin Exp Immunol. 1995 Nov;102(2):379-83
pubmed: 7586694
Genes Immun. 2001 Jun;2(4):222-8
pubmed: 11477478
Clin Hemorheol Microcirc. 2017;67(3-4):319-326
pubmed: 28885200
Epidemiol Prev. 2014 Nov-Dec;38(6 Suppl 1):1-122
pubmed: 25759295
Infect Immun. 2012 Mar;80(3):1140-9
pubmed: 22158745
Oncol Lett. 2019 Jan;17(1):623-629
pubmed: 30655809

Auteurs

Sabina Cauci (S)

Department of Medicine, University of Udine, I-33100 Udine, Italy.

Cinzia Buligan (C)

Department of Medicine, University of Udine, I-33100 Udine, Italy.
Department of Dermatology, University-Hospital of Udine, I-33100 Udine, Italy.

Francesco Rocchi (F)

Department of Medicine, University of Udine, I-33100 Udine, Italy.

Ilaria Salvador (I)

Department of Medicine, University of Udine, I-33100 Udine, Italy.

Luigi Xodo (L)

Department of Medicine, University of Udine, I-33100 Udine, Italy.

Giuseppe Stinco (G)

Department of Medicine, University of Udine, I-33100 Udine, Italy.
Department of Dermatology, University-Hospital of Udine, I-33100 Udine, Italy.

Classifications MeSH